share_log

ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment -- Barrons.com

ResMed CEO: Weight-Loss Drugs Aren't Cutting Demand for Sleep Apnea Treatment -- Barrons.com

瑞思迈首席执行官:减肥药物并不能减少对睡眠呼吸暂停治疗的需求 — Barrons.com
Barron's ·  01/29 00:30

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发